At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adherence to PTH(1-84) Treatment in Europe. A Non-interventional Cohort Study Collecting Safety Information and Examining Reasons and Predictors for Adherence to PTH(1-84) Treatment in Usual Clinical Settings
In Brief
An observational study evaluating Parathyroid Hormone (PTH) (1-84) for Clinical Use of PTH(1-84). Completed, enrolled 1,179 participants across 1 site.
Detailed Summary
The primary objective is: 1\) to describe adherence (and the main factors influencing adherence) to PTH(1-84) treatment when prescribed in a normal clinical setting. The secondary objectives are: 1. to describe the demographics and clinical characteristics of the patients that in a normal clinical setting are started on a treatment regimen with PTH(1-84) 2. to describe (using available data) the long term treatment effectiveness during the 24 months following initiation of PTH(1-84) treatment in a normal clinical setting 3. to monitor safety for 24 months following initiation of PTH(1-84) treatment in a patient in a normal clinical setting.
Study Details
Timeline
Interventions
Adherence to PTH(1-84) treatment in Usual Clinical Settings